This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Allen D. Roses, MD; Ann M. Saunders, PhD; Mark A. Alberts, MD; Warren J. Strittmatter, MD; Donald Schmechel, MD; Elizabeth Gorder, PhD; Margaret A. Pericak-Vance, PhD
Duke University Medical Center Durham, NC

JAMA. 1995;273(5):374-375.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In response to the letter by Dr Frisoni and colleagues¹ that reported a series of 42 vascular dementia patients with an apolipoprotein E (apo E)^E4 allele frequency equivalent to that reported for Alzheimer's disease (AD), we believe that their cases represent AD patients who share a clinically suggested diagnosis of vascular dementia.

Frisoni et al do not provide convincing evidence that their patients diagnosed as having vascular dementia do not also have AD. The cited "research criteria" (NINDS-AIREN²) provide for a diagnosis of probable or possible vascular dementia during life. These research criteria have yet to be tested with postmortem validation. It should also be noted that Roman and Tatemichi, coauthors of the published NINDS-AIREN criteria, more recently commented that the "criteria do not dismiss the coexistence of AD and vascular dementia."3 Roman and Tatemichi also commented that "in the absence of laboratory tests . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?